Physician in the Loop
For youSign in
Neurology ·

FDA takes XCath's remote stroke thrombectomy robot into TAP pilot; consortium develops robotic implantation for graphene brain implants

A tuning fork with clamp-on weights on its tines, standing upright on its round foot, with two pairs of short amber arcs beside the tines showing vibration.
THE SHORT READ

The Food and Drug Administration (FDA) accepted XCath's Iris system, a robot intended for remote thrombectomy in acute ischemic stroke, into its Total Product Life Cycle Advisory Program pilot, the company said. Separately, Inbrain Neuroelectronics and the MINIGRAPH consortium reported a robotic method for implanting ultra-thin graphene brain-computer interfaces, validated in a large animal model.

THE DETAILS
  • FDA Oct 8, 2026
    FDA accepts XCath's Iris robot for remote stroke thrombectomy into TAP pilot after September breakthrough designation
    XCath said the Food and Drug Administration (FDA) accepted its Iris surgical robotic system into the Total Product Life Cycle Advisory Program (TAP) pilot, after granting it Breakthrough Device designation in September 2026. The system is intended for remote, robotic-assisted mechanical thrombectomy in acute ischemic stroke. In March 2026, an early Iris system was operated from a control station in Santiago, Panama, to treat a patient more than 120 miles away, according to NeuroNews International. The company said the system remains under development and TAP enrollment does not guarantee FDA authorization.
    Source: NeuroNews International
  • Technology Oct 7, 2026
    Inbrain-led MINIGRAPH consortium validates robotic implantation of ultra-thin graphene brain-computer interfaces in large animals
    Inbrain Neuroelectronics and the MINIGRAPH consortium, a European Innovation Council-funded project, said they developed ultra-thin graphene neural interfaces and a minimally invasive robotic implantation procedure based on remote magnetic navigation. The procedure was validated in vitro and in vivo in a large animal model, according to NeuroNews International. The consortium reported more than 10 years of projected stability in accelerated aging tests and electronics capable of decoding signals from hundreds of neural sites. Nanoflex Robotics and ETH Zurich developed the robotic system, which its developers said reached submillimeter accuracy.
    Source: NeuroNews International

The weekly innovation roundup for neurology, published every Sunday for the week before; every item links to its sources. Latest neurology news · All specialties